» Articles » PMID: 28447102

Multimodal Breast Cancer Imaging Using Coregistered Dynamic Diffuse Optical Tomography and Digital Breast Tomosynthesis

Abstract

Diffuse optical tomography (DOT) is emerging as a noninvasive functional imaging method for breast cancer diagnosis and neoadjuvant chemotherapy monitoring. In particular, the multimodal approach of combining DOT with x-ray digital breast tomosynthesis (DBT) is especially synergistic as DBT prior information can be used to enhance the DOT reconstruction. DOT, in turn, provides a functional information overlay onto the mammographic images, increasing sensitivity and specificity to cancer pathology. We describe a dynamic DOT apparatus designed for tight integration with commercial DBT scanners and providing a fast (up to 1 Hz) image acquisition rate to enable tracking hemodynamic changes induced by the mammographic breast compression. The system integrates 96 continuous-wave and 24 frequency-domain source locations as well as 32 continuous wave and 20 frequency-domain detection locations into low-profile plastic plates that can easily mate to the DBT compression paddle and x-ray detector cover, respectively. We demonstrate system performance using static and dynamic tissue-like phantoms as well as in vivo images acquired from the pool of patients recalled for breast biopsies at the Massachusetts General Hospital Breast Imaging Division.

Citing Articles

Widefield ultra-high-density optical breast tomography system supplementing x-ray mammography.

Mireles M, Xu E, Vanegas M, Muldoon A, Ragunathan R, Yan S Sci Rep. 2025; 15(1):8732.

PMID: 40082492 PMC: 11906649. DOI: 10.1038/s41598-025-92261-9.


Evolution of tomosynthesis.

Goodsitt M, Maidment A J Med Imaging (Bellingham). 2025; 12(Suppl 1):S13012.

PMID: 39950185 PMC: 11817815. DOI: 10.1117/1.JMI.12.S1.S13012.


Monitoring of neoadjuvant chemotherapy through time domain diffuse optics: breast tissue composition changes and collagen discriminative potential.

Mule N, Maffeis G, Cubeddu R, Santangelo C, Bianchini G, Panizza P Biomed Opt Express. 2024; 15(8):4842-4858.

PMID: 39346975 PMC: 11427201. DOI: 10.1364/BOE.527968.


In vivo optimization of the experimental conditions for the non-invasive optical assessment of breast density.

Serra N, Cubeddu R, Maffeis G, Damagatla V, Pifferi A, Taroni P Sci Rep. 2024; 14(1):19154.

PMID: 39160254 PMC: 11333589. DOI: 10.1038/s41598-024-70099-x.


Functional hemodynamic imaging markers for the prediction of pathological outcomes in breast cancer patients treated with neoadjuvant chemotherapy.

Deng B, Muldoon A, Cormier J, Mercaldo N, Niehoff E, Moffett N J Biomed Opt. 2024; 29(6):066001.

PMID: 38737790 PMC: 11088438. DOI: 10.1117/1.JBO.29.6.066001.


References
1.
Brooksby B, Jiang S, Dehghani H, Pogue B, Paulsen K, Weaver J . Combining near-infrared tomography and magnetic resonance imaging to study in vivo breast tissue: implementation of a Laplacian-type regularization to incorporate magnetic resonance structure. J Biomed Opt. 2005; 10(5):051504. DOI: 10.1117/1.2098627. View

2.
Durduran T, Choe R, Baker W, Yodh A . Diffuse Optics for Tissue Monitoring and Tomography. Rep Prog Phys. 2015; 73(7). PMC: 4482362. DOI: 10.1088/0034-4885/73/7/076701. View

3.
Pisano E, Gatsonis C, Hendrick E, Yaffe M, Baum J, Acharyya S . Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005; 353(17):1773-83. DOI: 10.1056/NEJMoa052911. View

4.
Caldarella C, Treglia G, Giordano A . Diagnostic performance of dedicated positron emission mammography using fluorine-18-fluorodeoxyglucose in women with suspicious breast lesions: a meta-analysis. Clin Breast Cancer. 2014; 14(4):241-8. DOI: 10.1016/j.clbc.2013.12.004. View

5.
Zimmermann B, Fang Q, Boas D, Carp S . Frequency domain near-infrared multiwavelength imager design using high-speed, direct analog-to-digital conversion. J Biomed Opt. 2016; 21(1):16010. PMC: 4726736. DOI: 10.1117/1.JBO.21.1.016010. View